Menu
Cart 0
In Vitro Fertilisation (IVF) Market

In Vitro Fertilisation (IVF) Market - Forecasts from 2017 to 2022

  • $3,800.00
  • Publishing Date: January 2017
  • Format: PDF
Sample Request

In 2022, the market for In Vitro Fertilization (IVF) is expected to reach US$13.498 billion, increasing from US$8.418 billion in 2017, growing at a CAGR of 9.90%. In vitro fertilization (IVF) is a procedure used to treat fertility problems and support conception of a child by collecting mature eggs from a healthy woman’s ovaries and fertilizing them in a laboratory. Demand for IVF procedures has increased in recent years, owing to rising awareness and social acceptability. Factors driving growth in the market are increasing number of cases of infertility owing to lifestyle changes involving unhealthy nutritional habits, penetration of advanced procedures in developing nations, and favorable government initiatives. Geographically, Asia-Pacific is expected to witness the highest growth owing to rising aging population in Japan, favorable childbearing policies in China and rising awareness in countries like India, South Korea, and Thailand.

Research Methodology

This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.

Market Dynamics

In this section, the entire market is explained along with various drivers, restraints, and opportunities which exist in the current market. This section of the report also provides product pipeline, industry value chain analysis, and innovations in the market. Various regulations in the industry along with a scenario analysis have also been covered as a part of this report section.

Segmentation

In Vitro Fertilization (IVF) Market has been segmented on the basis of technique, product, donor type, end user and geography as follows:

  • By Technique
    • ICSI
    • PGD
    • FER
    • Others
  • By Product
    • Instruments
    • Reagents
  • By Donor Type
    • Fresh Donor
    • Frozen Donor
  • By End-User
    • Hospitals and Clinics
    • Research Laboratories
    • Others
  • By Geography
    • Americas
      • North America
      • South America
    • Europe Middle East and Africa
      • Europe
      • The Middle East and Africa
    • Asia Pacific

Market Players

The competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Vitrolife AB, Irvine scientific, Thermo Fisher Scientific and Ovascience Inc. among others.
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Industry Value Chain Analysis
4.6. Product Pipeline
4.7. Innovations
4.8. Industry Regulations
4.9. Scenario Analysis
5. In Vitro Fertilization (IVF) Market Forecast by Technique (US$ billion)
5.1. ICSI
5.2. PGD
5.3. FER
5.4. Others
6. In Vitro Fertilization (IVF) Market Forecast by Product (US$ billion)
6.1. Instruments
6.2. Reagents
7.  In Vitro Fertilization (IVF) Market Forecast by Donor Type (US$ billion)
7.1. Fresh Donor
7.2. Frozen Donor
8. In Vitro Fertilization (IVF) Market Forecast by End-User (US$ billion)
8.1. Hospitals and Clinics
8.2. Research Laboratories
8.3. Others
9. In Vitro Fertilization (IVF) Market by Geography (US$ billion)
9.1. Americas
9.1.1. North America
9.1.2. South America
9.2. Europe Middle East and Africa
9.2.1. Europe
9.2.2. The Middle East and Africa
9.3. Asia Pacific
10. Competitive Intelligence
10.1. Market Share of Key Players
10.2. Investment Analysis
10.3. Recent Deals
10.4. Strategies of Key Players
11. Company Profiles
11.1. Vitrolife AB
11.2. Irvine scientific
11.3. Thermo Fisher Scientific
11.4. Ovascience Inc.
11.5. Merck KGaA
11.6. Genea Biomedx
11.7. Oxford Gene Technology
11.8. Progyny, Inc.

Related Reports
Back to the top